Enhance: A multi-centre, randomised phase IV study
Introduction: This collaborative study compares newer formulations of oxycodone across different settings for people with cancer
Title - Enhance: A multi-centre, randomised, phase IV study to compare the efficacy of oxycodone/naloxone verses oxycodone prolonged release tablets in patients with advanced cancer
Key Aim To evaluate two pain relief medications, oxycodone/naloxone prolonged-release (OXN PR) and oxycodone alone prolonged-release (Oxy PR) with respect to analgesic efficacy and constipation in patients with advanced cancer.
Principal Investigator: Dr Aaron Wong, Peter MacCallum Cancer Centre (Aaron.firstname.lastname@example.org)
Faculty Research Themes
School Research Themes
For further information about this research, please contact the research group leader.
Department / Centre
St Vincent's Hospital
MDHS Research library
Explore by researcher, school, project or topic.